ISABEL MANUELA
ÁLVAREZ LÓPEZ
Hospital General Universitario de Elche
Elche, EspañaHospital General Universitario de Elche -ko ikertzaileekin lankidetzan egindako argitalpenak (14)
2023
-
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry
Breast Cancer Research and Treatment, Vol. 201, Núm. 2, pp. 151-159
2018
-
Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-study
European Journal of Cancer, Vol. 94, pp. 199-205
-
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy
Clinical and Translational Oncology, Vol. 20, Núm. 12, pp. 1548-1556
2017
-
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624
2013
2012
-
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers
BMC Medical Genomics, Vol. 5
2010
-
Current controversies in the management of breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286
-
Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))
Clinical and Translational Oncology
-
SEOM clinical guidelines for the treatment of metastatic breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 719-723
2008
-
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814
2007
-
Advanced breast cancer: Chemotherapy phase III trials that change a standard
Anti-Cancer Drugs
-
Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials
Cancer Treatment Reviews, Vol. 33, Núm. 5, pp. 474-483
-
The use of taxanes in the neoadjuvant treatment of breast cancer: A review of randomized phase II/III trials
Clinical Breast Cancer, Vol. 7, Núm. 10, pp. 764-774